Multiple Myeloma Treatment Market, By Type (Drug Therapy, Stem Cell Transplantation, Biophosphonates, Radiation Therapy, & Surgical Therapy) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

The report titled “Multiple Myeloma Treatment Market- Growth, Future Prospects, and Competitive Analysis, 2017 – 2025” offers strategic insights into the overall multiple myeloma treatment market along with the market size and estimates for the duration 2015 to 2025. The said research study cover in-depth analysis of multiple myeloma market segments based on type and different geographies further segmented by countries. According to myeloma UK, in myeloma, plasma cells become abnormal, multiply uncontrollably and release only one type of antibody known as paraprotein, which has no useful function. It is often through the measurement of this paraprotein that myeloma is diagnosed and monitored.

For the purpose of this study, the global multiple myeloma treatment market is segmented on the basis of type into Drug Therapy, Stem cell Transplantation, Biophosphonates, Radiation Therapy, & Surgical Therapy. Drug therapy is further segmented into monoclonal antibodies, immunomodulatory drugs, proteasome inhibitors, chemotherapy, histone deacetylase inhibitor, and corticosteroids. Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2017 to 2025, considering 2016 as the base year.

The geographical segmentation of multiple myeloma treatment market comprised regions such as North America, Europe, Asia-Pacific, Latin America & Middle East and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa, and other countries. Market size and forecast for these segments during 2015 to 2025 and their CAGRs for the period 2017 to 2025 are provided in this report.

The multiple myeloma treatment market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are Celgene Corporation, Janssen Biotech, Inc., Bristol-Myers Squibb Company, Novartis AG, Millennium Pharmaceuticals, Amgen, Inc., Genzyme Corporation, Juno Therapeutics, among others.

Choose License Type
Published Date:  Sep 2017
Category:  Pharmaceuticals
Report ID:   58685
Report Format:   PDF
Pages:   120
Rating:    4.4 (60)
Connect With Us
+1-408-641-3282
24/7 Research Support